Aarti Drugs logo

Aarti Drugs Q1 results, quarter to Jun 2026

NSE: AARTIDRUGSBSE: 524348Pharmaceuticals & BiotechnologySmall Cap

Aarti Drugs Limited · Face value ₹10 · Listed Sep 1993 on BSE, Sep 2003 on NSE
Last close ₹449.00up ₹1.10 (0.25%)BSE ₹448.95

Share price at the NSE close on 29 Oct 2026. Previous close ₹447.90.

29 Oct: open ₹440.00, high ₹457.95, low ₹434.25

52-week range of traded prices to 29 Oct 2026
₹318.95Low, 30 Mar 2026₹534.00High, 10 Nov 2025
Market cap
₹4,098 Cr930th largest listed
P/E
21.44
P/B
2.65
Dividend yield
0.45%
ROE
13.1%
ROCE
12.4%
Debt to equity
0.37
Volume, NSE
9,51,96822.6% delivered

Aarti Drugs filed its Q1 results for the quarter to Jun 2026 on 31 Jul 2026 at 8:44 pm, consolidated: the company and its subsidiaries together.

Q1 results, quarter to Jun 2026

₹ crore.Aarti Drugs annual results and balance sheet

Revenue
₹703 Cr+19.0% on a year ago · −2.4% on the quarter before
Operating profit
₹98 Cr+32.6% on a year ago · +2.5% on the quarter before
Net profit
₹50 Cr−7.1% on a year ago · −9.3% on the quarter before
Earnings per share
₹5.49−7.1% on a year ago · −9.3% on the quarter before
Operating margin
14.0%
Net margin
7.1%

From revenue to net profit, ₹ crore

  1. Revenue703
  2. Materials and goods−428
  3. Employee costs−37
  4. Other expenses−140
  5. Operating profit98
  6. Depreciation−18
  7. Other income+0.8
  8. One-off items−2.1
  9. Finance costs−9.2
  10. Profit before tax69
  11. Tax−19
  12. Net profit50

Aarti Drugs results by quarter

Consolidated: the company and its subsidiaries together. Latest quarter to Jun 2026. Results for the quarter to Sep 2026 are due by 14 Nov 2026, 45 days after it ends. Every company's dates are on the results calendar.Results filings and date

Revenue and net profit by quarter, ₹ crore

  • Revenue
  • Net profit
64240Sep 2360637Dec 2362047Mar 2455533Jun 2459835Sep 2455737Dec 2467763Mar 2559154Jun 2565345Sep 2560241Dec 2572055Mar 2670350Jun 26
Peak revenue ₹720 Cr, quarter to Mar 2026; lowest ₹555 Cr, quarter to Jun 2024

Operating and net margin by quarter, per cent

  • Operating margin
  • Net margin
14.0%5.8%11.9%11.6%13.8%11.7%11.2%11.1%13.8%12.5%12.9%9.1%13.3%14.0%6.2%6.1%7.6%6.0%5.8%6.7%9.3%9.1%6.9%6.7%7.7%7.1%Sep 23Mar 24Sep 24Mar 25Sep 25Mar 26Jun 26
₹ croreSep 2021Dec 2021Q3Mar 2022Jun 2022Q1Sep 2022Dec 2022Q3Mar 2023Jun 2023Q1Sep 2023Dec 2023Q3Mar 2024Jun 2024Q1Sep 2024Dec 2024Q3Mar 2025Q4Jun 2025Q1Sep 2025Q2Filed 7 NovDec 2025Q3Filed 3 FebMar 2026Q4Filed 15 MayJun 2026Q1
Revenue from operations580635694622688664742661642606620555598557677591653602720703
506545608555613593649577565536534490531495583516569547625605
Materials and goods bought396419478429481463516446429405397360394351437373408387450428
Employee costs2121222122242525252626262728313133333237
Other expenses90104109105110107108105111105111104111116115112127127142140
Operating profit before depreciation7490866774719484767086656762937484559698
Operating margin12.7%14.2%12.4%10.8%10.8%10.6%12.6%12.7%11.9%11.6%13.8%11.7%11.2%11.1%13.8%12.5%12.9%9.1%13.3%14.0%
Depreciation and amortisation1213131313131313131314131414151516181818
Other income073001111211112200111
Finance costs55678999889999998989
Profit before one-off items and tax5679714853507364565264444651715160297071
One-off items0000000000000000000−2
Profit before tax5679714853507364565264444651715160297069
14201513141317161715171111148−315−121519
Tax rate24.1%25.9%21.5%27.6%27.2%26.2%23.3%24.5%29.6%28.8%26.3%24.4%23.8%26.9%11.8%−5.6%25.2%−39.7%21.5%27.6%
4358553539375648403747333537635445415550
Other comprehensive income001000−20000000100030
Total comprehensive income4358563539375548403747343537645445415850
Net margin7.3%9.2%8.0%5.6%5.6%5.5%7.6%7.3%6.2%6.1%7.6%6.0%5.8%6.7%9.3%9.1%6.9%6.7%7.7%7.1%
Earnings per share₹4.60₹6.29₹5.97₹3.76₹4.18₹3.96₹6.07₹5.18₹4.29₹3.99₹5.15₹3.62₹3.83₹4.06₹6.88₹5.91₹4.95₹4.44₹6.05₹5.49
Earnings per share in rupees, restated for later splits and bonuses.